HTB Business Summary

Hantech Bio-Technology (1294.TWO), also known as HTB, operates as a specialized contract development and manufacturing organization (CDMO) within the global nutraceutical and functional food industry. The company generates revenue through a business-to-business (B2B) model, providing comprehensive OEM and ODM services that encompass product formulation, clinical validation, and advanced packaging solutions. Its primary business segments are categorized by delivery formats, specifically liquid, gel, jelly, and powder supplements, with a market-leading focus on its proprietary aluminum foil pouch packaging technology. HTB competes directly with Taiwan-based biotech manufacturers such as Shiny Brands Group (6703.TWO), G&E Herbal Biotechnology (4911.TWO), and Far East Bio-Tec (6886.TWO). Within this competitive landscape, HTB maintains a high-density niche as a technology-driven partner, leveraging its extensive international certifications (ISO22000, HACCP, HALAL, and GMP) to provide rapid, scalable manufacturing for global health brands seeking customized, science-backed products. The company is led by Chairman and CEO Yulin Li, who founded HTB in 2007 with a vision to integrate pharmaceutical-grade manufacturing standards into the health supplement sector. Under Li’s leadership, the executive team has established a pedigree in food science and industrial automation, overseeing the company’s expansion into a state-of-the-art production hub in Yuanlin, Changhua County. The management team is supported by a board of directors composed of industry veterans with expertise in global supply chain logistics and biotechnology R&D. HTB’s strategic direction is further reinforced by a stable base of institutional investors who prioritize the company’s alignment with international regulatory trends and the rising consumer demand for portable, eco-friendly health solutions. As of 2026, the leadership continues to focus on R&D in high-concentration herbal extracts and automated 'pouch-filling' systems to sustain its competitive edge in the regional biotech market.